Global health reaped a weekend windfall of new international and bilateral commitments over the past two days, beginning with the close of the G20 meeting in Argentina on Saturday, followed by the Mandela 100 Global Citizen festival in Johannesburg yesterday, which saw stars like Beyoncé, Jay-Z and others perform in the name of health and development causes, reaping a historic commitment by the United States of more than US$1.2 billion for the fight against HIV/AIDS and some US$ 139 million for the fight against neglected tropical diseases. Continue reading ->
A report launched jointly today by Population Services International (PSI), London School of Hygiene and Tropical Medicine and the World Health Organization shows that people’s knowledge of their HIV status in sub-Saharan African countries nearly doubled just four years after self-testing programmes were introduced. Separately, a group of French NGOs called on the French President to lead elimination of HIV/AIDS, tuberculosis and malaria by 2030. Continue reading ->
NAIROBI, Kenya -- “I got married at the age of 20 years seven years ago, just a year after finishing secondary school. My intention was to give birth to only two kids but my husband and his parents could hear none of it. Matters got worse when my second born turned out to be a girl like the eldest kid. My in-laws who live in rural Western Kenya said my husband was their only son so he was supposed to sire sons to inherit their land,” says Judy Akinyi (not her real name), a resident of Korogocho slum in the east of Nairobi. Continue reading ->
Clemens Martin Auer, director general of Austria’s Ministry of Health, could be said to take a pragmatic and original perspective when it comes to European and national policy. In an interview with Health Policy Watch during the recent European Health Forum in Bad Gastein, Austria, he discussed health priorities for the current Austrian presidency of the European Union and beyond. He also discussed ongoing efforts by a number of European countries to address high prices of medicines and public funding for R&D. This is the second of two parts. Continue reading ->